Medication info
Candesartan Plus 16/12.5 mg Tablet

Candesartan Plus 16/12.5 mg Tablet

Prescription medicationTabletOral
Ingredient · strength
Candesartan Cilexetil›16mg / 1 tabletHydrochlorothiazide›12.5mg / 1 tablet
Manufacturer / importer
Daewoong Bio Co., Ltd.
Appearance
Light orange oval tablet with a score line on one side.
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 202003552 · Approved 2020.05.15 · Insurance code 694003030

Summary

Main use
Treatment of essential hypertension inadequately controlled with the individual components
Who takes it
Adults
Adult dose
The recommended dose of this medicine is 1 tablet once daily, with or without food. 1) Adults: The dose of candesartan cilexetil should first be adjusted before switching to this medicine. When clinically appropriate, a direct switch from monotherapy to this medicine may be considered. The antihypertensive effect is generally achieved within 4 weeks of starting treatment. 2) Elderly patients: No dose adjustment of this medicine is necessary in elderly patients. 3) Patients with intravascular volume depletion: Adjustment of the candesartan cilexetil dose is recommended in patients at risk of hypotension, such as those who may have reduced effective blood volume (the initial dose of candesartan cilexetil in these patients is 4 milligrams). 4) Patients with renal impairment: In patients with mild to moderate renal impairment and creatinine clearance of 30-80ml/min/1.73㎡ BSA, consider adjusting the candesartan cilexetil dose before switching to this medicine (the initial dose of candesartan cilexetil in these patients is 4 milligrams). Do not administer to patients with severe renal impairment (creatinine clearance less than 30ml/mim/1.73㎡ BSA). 5) Patients with hepatic impairment: It is recommended to adjust the candesartan cilexetil dose before administering this medicine to patients with mild to moderate hepatic impairment (the initial dose of candesartan cilexetil in these patients is 2 milligrams). Do not administer to patients with severe hepatic impairment or cholestasis.

Ingredients

Manufacturer
Daewoong Bio Co., Ltd.

Efficacy & effects

Treatment of essential hypertension inadequately controlled with the individual components

  • Essential hypertension
View approved original text

This medication is used for patients with essential hypertension, who may not achieve sufficient effect with single component alone, to effectively control blood pressure and help reduce the risk of cardiovascular complications.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet once daily, with or without food. 1) Adults: The dose of candesartan cilexetil should first be adjusted before switching to this medicine. When clinically appropriate, a direct switch from monotherapy to this medicine may be considered. The antihypertensive effect is generally achieved within 4 weeks of starting treatment. 2) Elderly patients: No dose adjustment of this medicine is necessary in elderly patients. 3) Patients with intravascular volume depletion: Adjustment of the candesartan cilexetil dose is recommended in patients at risk of hypotension, such as those who may have reduced effective blood volume (the initial dose of candesartan cilexetil in these patients is 4 milligrams). 4) Patients with renal impairment: In patients with mild to moderate renal impairment and creatinine clearance of 30-80ml/min/1.73㎡ BSA, consider adjusting the candesartan cilexetil dose before switching to this medicine (the initial dose of candesartan cilexetil in these patients is 4 milligrams). Do not administer to patients with severe renal impairment (creatinine clearance less than 30ml/mim/1.73㎡ BSA). 5) Patients with hepatic impairment: It is recommended to adjust the candesartan cilexetil dose before administering this medicine to patients with mild to moderate hepatic impairment (the initial dose of candesartan cilexetil in these patients is 2 milligrams). Do not administer to patients with severe hepatic impairment or cholestasis.

Precautions

This medication can cause serious harm to the fetus or newborn when taken during pregnancy, especially in the second and third trimesters; therefore, it should be discontinued immediately upon confirmation of pregnancy. Patients allergic to this medication’s ingredients or sulfonamide drugs, those with acute or severe renal disease, severe liver disease, history of certain angioedema, or gout should not take this medication. Patients with depleted blood volume or sodium deficiency, liver disease, severe cardiac valve disease, or hyperkalemia should use this medication with caution, and it is advisable to abstain from use until symptoms improve. This medication may lower blood pressure, leading to side effects such as dizziness, headaches, and fatigue; rare adverse reactions including blood or liver function abnormalities, skin rashes, and myalgia have been reported. This medication may affect kidney function, so patients with kidney disease should undergo regular blood tests and electrolyte checks and be cautious of interactions when with other antihypertensives or diuretics. This medication can be excreted in breast milk, so breastfeeding women should decide on use after consultation with a physician. Elderly patients should be cautious with this medication as too low blood pressure may strain the heart or kidneys. In case of overdose, symptoms such as hypotension, dizziness, and dehydration may occur, necessitating immediate medical assistance. During medication, protect against skin damage from sunlight by taking precautions against ultraviolet exposure, and inform medical staff immediately if skin changes occur. Additionally, caution is necessary when driving or operating machinery as dizziness or lethargy may be experienced.

Side effects

Headache, back pain, dizziness, respiratory tract infection, symptoms similar to an influenza-like illness, sinusitis, bronchitis, urinary tract infection, nausea, contusion, tachycardia, fatigue, abdominal pain, pharyngitis, heart block, vomiting, dyslipidemia, nasopharyngitis, cough, elevated blood sugar, increased serum uric acid, elevated ALT, decreased hemoglobin, increased serum AST, increased creatinine, increased urea, increased potassium, decreased sodium, leukopenia, neutropenia, agranulocytosis, vertigo, intestinal vascular edema, diarrhea, renal failure, angioedema, rash, urticaria, pruritus, arthralgia, myalgia, hyperkalemia, hyponatremia, increased liver enzyme levels, abnormal liver function, hepatitis, cardiac arrhythmia, sensory disturbances, transient visual disturbances, choroidal effusion, acute myopia, acute angle-closure glaucoma, dyspnea, acute respiratory distress syndrome, loss of appetite, appetite loss, gastrointestinal irritation, constipation, pancreatitis, interstitial nephritis, rash, photosensitive reaction, toxic epidermal necrolysis, skin erythematous lupus-like reaction, activation of erythematous lupus, muscle cramps, hyperglycemia, hyperuricemia, electrolyte imbalance, orthostatic hypotension, necrotizing vasculitis, weakness, fever, anaphylactic reaction, jaundice, sleep disorders, depression, anxiety, edema, myalgia, hypercalcemia, pain during urination

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent air and moisture exposure, preferably at a cool temperature below 30 degrees Celsius. Storing it this way will maintain the drug's efficacy and prevent degradation.

Appearance and packaging

Appearance

Light orange oval tablet with a score line on one side.

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.